Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation
Authors
Keywords
-
Journal
Nutrients
Volume 11, Issue 10, Pages 2523
Publisher
MDPI AG
Online
2019-10-21
DOI
10.3390/nu11102523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening Pyridine Derivatives against Human Hydrogen Sulfide-synthesizing Enzymes by Orthogonal Methods
- (2019) Karim Zuhra et al. Scientific Reports
- A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?
- (2018) Xu Cao et al. ANTIOXIDANTS & REDOX SIGNALING
- Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer
- (2018) Sofia C. Nunes et al. BMC EVOLUTIONARY BIOLOGY
- Cystathionine β-synthase regulates mitochondrial morphogenesis in ovarian cancer
- (2018) Prabir Kumar Chakraborty et al. FASEB JOURNAL
- Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment
- (2018) Valentina Gandin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Glutathione in Ovarian Cancer: A Double-Edged Sword
- (2018) Sofia Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
- (2018) Andrea Rizzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Strategies for the development of selenium-based anticancer drugs
- (2018) Philippe Collery JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Alterations in System xc− Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2
- (2018) Raul Carpi-Santos et al. MOLECULAR NEUROBIOLOGY
- Hydrogen Sulfide Biochemistry and Interplay with Other Gaseous Mediators in Mammalian Physiology
- (2018) Alessandro Giuffrè et al. Oxidative Medicine and Cellular Longevity
- Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma
- (2018) Masaki Nagane et al. PLoS One
- Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo
- (2018) Xihui Wang et al. Targeted Oncology
- Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors
- (2018) Raeeka Khamari et al. Cell Death & Disease
- Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
- (2018) Sofia C. Nunes et al. Scientific Reports
- Oxidative stress induced by carboplatin promotes apoptosis and inhibits migration of HN‑3 cells
- (2018) Pei‑Jie He et al. Oncology Letters
- Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms
- (2017) Nádia M. Grilo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Comparison of the redox chemistry of sulfur- and selenium-containing analogs of uracil
- (2017) N. Connor Payne et al. FREE RADICAL BIOLOGY AND MEDICINE
- The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate
- (2017) Pranavi Koppula et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selenium uptake through cystine transporter mediated by glutathione conjugation
- (2017) Takao Tobe et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties
- (2017) Monika D. Polewski et al. STEM CELLS AND DEVELOPMENT
- The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility
- (2017) Chun-Shik Shin et al. Nature Communications
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
- (2016) Gwo Yaw Ho et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
- (2016) A. L. Furfaro et al. Oxidative Medicine and Cellular Longevity
- ROS homeostasis and metabolism: a dangerous liason in cancer cells
- (2016) E Panieri et al. Cell Death & Disease
- Sulfasalazine inhibits inflammation and fibrogenesis in pancreas via NF-κB signaling pathway in rats with oxidative stress-induced pancreatic injury
- (2016) Ming-Xian Yan et al. Drug Design Development and Therapy
- EAAT3 promotes amino acid transport and proliferation of porcine intestinal epithelial cells
- (2016) Jin-ling Ye et al. Oncotarget
- Chemoresistance and targeted therapies in ovarian and endometrial cancers
- (2016) Kevin Brasseur et al. Oncotarget
- Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway
- (2016) Sheng-Fan Wang et al. Oncotarget
- The Therapeutic Potential of Cystathionine β-Synthetase/Hydrogen Sulfide Inhibition in Cancer
- (2015) Mark R. Hellmich et al. ANTIOXIDANTS & REDOX SIGNALING
- Suppression of inflammatory response by chrysin, a flavone isolated from Potentilla evestita Th. Wolf. In silico predictive study on its mechanistic effect
- (2015) Abdur Rauf et al. FITOTERAPIA
- Role of cystathionine β-synthase in human breast Cancer
- (2015) Suvajit Sen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Selenium-Containing Chrysin and Quercetin Derivatives: Attractive Scaffolds for Cancer Therapy
- (2015) Inês L. Martins et al. JOURNAL OF MEDICINAL CHEMISTRY
- POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50Lowering Capacity
- (2015) Rita B. Restani et al. MACROMOLECULAR BIOSCIENCE
- Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function
- (2015) LIANGYU CHEN et al. ONCOLOGY REPORTS
- HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)
- (2015) Filipa Lopes-Coelho et al. TUMOR BIOLOGY
- A metabolomic approach to identifying platinum resistance in ovarian cancer
- (2015) Laila M Poisson et al. Journal of Ovarian Research
- Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
- (2015) Prabir K Chakraborty et al. Oncotarget
- Hereditary Ovarian Cancer: Not OnlyBRCA1 and 2 Genes
- (2015) Angela Toss et al. Biomed Research International
- Expression of xCT and activity of system x c − are regulated by NRF2 in human breast cancer cells in response to oxidative stress
- (2015) Eric Habib et al. Redox Biology
- Flavones: An important scaffold for medicinal chemistry
- (2014) Manjinder Singh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- EPR: Evidence and fallacy
- (2014) Joseph W. Nichols et al. JOURNAL OF CONTROLLED RELEASE
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Cysteine Transport through Excitatory Amino Acid Transporter 3 (EAAT3)
- (2014) Spencer D. Watts et al. PLoS One
- Enzymology of H2S Biogenesis, Decay and Signaling
- (2013) Omer Kabil et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of Glutathione in Cancer Progression and Chemoresistance
- (2013) Nicola Traverso et al. Oxidative Medicine and Cellular Longevity
- Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance
- (2013) Sanjib Bhattacharyya et al. PLoS One
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
- (2013) Rossella Marullo et al. PLoS One
- Nanoparticle and targeted systems for cancer therapy
- (2012) Lisa Brannon-Peppas et al. ADVANCED DRUG DELIVERY REVIEWS
- Biocompatible Polyurea Dendrimers with pH-Dependent Fluorescence
- (2012) Rita B. Restani et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- The Gasotransmitter Hydrogen Sulfide Induces Nrf2-Target Genes by Inactivating the Keap1 Ubiquitin Ligase Substrate Adaptor Through Formation of a Disulfide Bond Between Cys-226 and Cys-613
- (2012) John M. Hourihan et al. ANTIOXIDANTS & REDOX SIGNALING
- Recent trends in cancer drug resistance reversal strategies using nanoparticles
- (2012) Srinath Palakurthi et al. Expert Opinion on Drug Delivery
- Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
- (2012) Rui Wang PHYSIOLOGICAL REVIEWS
- Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: The selenium paradox (Review)
- (2011) Daewon Jeong Molecular Medicine Reports
- Mechanisms of drug resistance in ovarian cancer
- (2010) Steven W. Johnson et al. CANCER
- Selenium in the prevention of human cancers
- (2010) Mikael Björnstedt et al. EPMA Journal
- Extracellular thiol-assisted selenium uptake dependent on the xc- cystine transporter explains the cancer-specific cytotoxicity of selenite
- (2009) E. Olm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase
- (2008) Christopher C. Franklin et al. MOLECULAR ASPECTS OF MEDICINE
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started